Adial PharmaceuticalsADIL
那斯達克 · USD
0.38
-0.01
(-2.26%)
收盤 08/30 03:50 (UTC+8)
盤後
0.38
0.38
(-1.29%)
08/30 03:50 (UTC+8)
Adial PharmaceuticalsADIL
0.38
-0.01
(-2.26%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 0 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 1,883 | - | - | 2,212 | - | - | - | 1,358 | 1,477 | 2,920 |
研發費用 | 732 | 747 | 731 | 1,032 | 1,013 | 454 | 264 | 207 | 430 | 676 |
推銷及管理費用 | 1,150 | 1,520 | 1,210 | 1,180 | 1,275 | 1,391 | 1,519 | 1,151 | 1,047 | 2,244 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,883 | -2,267 | -1,941 | -2,211 | -2,287 | -1,845 | -1,784 | -1,358 | -1,477 | -2,921 |
其他收入及費用 | - | 202 | -21 | 51 | 51 | -4,442 | 73 | 10 | -32 | 15 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -1,959 | -2,229 | -2,071 | -2,192 | -2,458 | -6,477 | -1,904 | -1,348 | -1,510 | -2,906 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -1,959 | -2,229 | -2,071 | -2,192 | -2,458 | -6,477 | -1,920 | -1,385 | 1,088 | -2,906 |
基本每股稅後盈餘(元) | -0.18 | -0.34 | 0.44 | -0.38 | -0.59 | -2.19 | - | -1.18 | 0.04 | -0.11 |
稀釋每股稅後盈餘(元) | -0.18 | -0.34 | -0.15 | -0.07 | -0.31 | -2.19 | -0.74 | -1.20 | 0.04 | -0.11 |
基本平均股數(千股) | - | 6539.00 | - | 5835.00 | 4182.00 | 2953.00 | - | 1178.00 | 28285.00 | 26463.00 |
稀釋平均股數(千股) | 10622.00 | 6539.00 | 6435.00 | 5835.00 | 4182.00 | 2953.00 | - | 1178.00 | 28285.00 | 26463.00 |
還原基本每股稅後盈餘(元) | -0.18 | -0.34 | 0.44 | -0.38 | -0.59 | -2.19 | - | -1.18 | 0.96 | -2.75 |
還原稀釋每股稅後盈餘(元) | -0.18 | -0.34 | -0.15 | -0.07 | -0.31 | -2.19 | -0.74 | -1.20 | 1.09 | -2.75 |
還原基本平均股數(千股) | - | 6,539 | - | 5,835 | 4,182 | 2,953 | - | 1,178 | 1,131 | 1,058 |
還原稀釋平均股數(千股) | 10,622 | 6,539 | 6,435 | 5,835 | 4,182 | 2,953 | - | 1,178 | 1,131 | 1,058 |
EBITDA(千元) | -1,959 | -2,229 | -2,071 | -2,192 | -2,458 | -6,477 | -1,920 | -1,385 | 1,088 | -2,890 |